DR Horton Increases Sales but Misses Revenue Estimate
DR Horton (NYS: DHI) reported earnings on Nov. 12. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Sep. 30 (Q4), DR Horton missed estimates on revenues and met expectations on earnings per share.
Compared to the prior-year quarter, revenue grew significantly and GAAP earnings per share grew significantly.
Margins expanded across the board.
DR Horton logged revenue of $1.34 billion. The 10 analysts polled by S&P Capital IQ expected sales of $1.38 billion on the same basis. GAAP reported sales were 22% higher than the prior-year quarter's $1.10 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.30. The 16 earnings estimates compiled by S&P Capital IQ forecast $0.30 per share. GAAP EPS of $0.30 for Q4 were 173% higher than the prior-year quarter's $0.11 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 18.4%, 210 basis points better than the prior-year quarter. Operating margin was 7.5%, 250 basis points better than the prior-year quarter. Net margin was 7.5%, 420 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $1.21 billion. On the bottom line, the average EPS estimate is $0.18.
Next year's average estimate for revenue is $5.50 billion. The average EPS estimate is $0.95.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 580 members out of 1,148 rating the stock outperform, and 568 members rating it underperform. Among 328 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 148 give DR Horton a green thumbs-up, and 180 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on DR Horton is hold, with an average price target of $20.75.
- Add DR Horton to My Watchlist.
The article DR Horton Increases Sales but Misses Revenue Estimate originally appeared on Fool.com.Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.